Rick Simpson Oil (RSO) in Chattooga County: The Complete Guide by OilWell Cannabis

If you’re reading this from Chattooga County, Georgia — whether you’re in Summerville, Trion, Lyerly, or out in the rural stretches near Cloudland Canyon — you’re likely looking for honest answers about Rick Simpson Oil. Maybe you’ve heard the stories. Maybe someone in your family is facing a cancer diagnosis and you’re searching for options beyond what the small medical facilities in our corner of northwest Georgia can offer. Maybe you’re dealing with chronic pain from years of physical labor in the mills or on the farms that built this county. Maybe you’re a veteran from Fort McPherson or one of our other regional bases who brought home trauma that no amount of VA medication seems to touch.

We understand. We’re OilWell Cannabis, and we built our company because we lived these same questions. We’re not a faceless corporation from some far-off state. We’re a Houston-based cannabis company founded by someone who grew up in one of the most challenging border regions in America, who learned the plant not from textbooks but from necessity, and who has spent seven years building a product line that doctors actually use for conditions like Crohn’s, PTSD, ulcerative colitis, and benzodiazepine addiction. We’ve been featured seven times on ABC13 Houston — not because we paid for publicity, but because when reporters need someone who tells the truth about cannabis, they call Colin Valencia, our founder.

And now we’re bringing that same level of transparent, evidence-based cannabis education directly to Chattooga County. This guide is for you. For your neighbors. For your community. No medical card required. No gatekeeping. Just the most comprehensive RSO education available anywhere, anchored in real science and presented with the humility and respect that Chattooga County folks expect when someone’s talking about their health.

Who Was Rick Simpson — And Why His Story Matters to Chattooga County

Rick Simpson was born in 1949 in Amherst, Nova Scotia, Canada. He wasn’t a doctor. He wasn’t a scientist. He was a power engineer and maintenance worker — a blue-collar tradesman whose path into cannabis began the same way many stories begin in rural communities like ours: the medical system failed him when he needed it most.

In 1997, while working at a hospital in Moncton, Simpson fell from scaffolding and suffered a serious head injury. The aftermath included persistent tinnitus, dizziness, and post-concussion symptoms that the doctors couldn’t fix. The medications they prescribed either didn’t help or made things worse. When he told his physician that cannabis was providing more relief than anything they’d given him, the doctor refused to support it. Sound familiar? Too many folks in Chattooga County have walked out of doctors’ offices feeling like they weren’t heard, like their pain wasn’t real, like the solutions being offered were just more pills that cause more problems.

Simpson’s interest in concentrated cannabis oil deepened after he learned about a 1974 NIH-funded study at the Medical College of Virginia, where THC was reported to slow or shrink tumors in mice. That study — which was actually trying to prove cannabis caused harm — became a cornerstone of Simpson’s advocacy, even though its findings were never replicated in controlled human cancer trials. But to someone who had been failed by conventional medicine, that early mouse study looked like hope.

The pivotal moment came in 2003. Simpson reported that three bumps on his arm were diagnosed as basal cell carcinoma. Instead of pursuing conventional treatment, he applied concentrated cannabis oil directly to the lesions, covered them with bandages, and waited four days. By his account, the bumps disappeared. No biopsy confirmation. No peer-reviewed documentation. No independent medical verification. Just a personal testimony that would become the origin story for what we now call Rick Simpson Oil.

Important context: Simpson’s account is his personal testimony. It cannot be evaluated as medical evidence because that evidence doesn’t exist. But it is historically significant as the catalyst for a global movement. In Chattooga County, where word-of-mouth and personal stories carry weight in every community from Menlo to Cloudland, we understand why this story resonates. We’ve all seen someone find relief when nothing else worked. But we also owe you honesty: personal testimony is not the same as clinical proof.

The Crusade: How RSO Spread From Nova Scotia to Chattooga County

After his 2003 experience, Simpson committed himself to making and giving away concentrated cannabis oil. He charged nothing. He operated out of Maccan, Nova Scotia, and by his own account helped dozens of people with cancer, chronic pain, diabetes, infections, glaucoma, arthritis, depression, insomnia, and more. He gave it away for free to anyone who asked.

Simpson’s story reached a global audience through the 2005 documentary Run From The Cure, which became one of the most widely shared cannabis advocacy films of its era. Within cannabis communities — including those that would eventually emerge in rural Georgia — this documentary was foundational. For many people, Run From The Cure was their first introduction to the idea that concentrated cannabis oil could be medicine.

But Simpson’s advocacy brought him into direct conflict with Canadian law. The Royal Canadian Mounted Police raided his property in 2005 and again in 2009. He was charged with cultivation, possession, and trafficking. Facing continued legal pressure, Simpson eventually left Canada for Europe. He lived in Croatia and later the Netherlands, continuing his advocacy from abroad while the industry he helped spark evolved without him.

In 2012, he published Phoenix Tears: The Rick Simpson Story and maintained phoenixtears.ca as his platform. Throughout his public career, Simpson maintained that RSO could cure cancer and that pharmaceutical companies, government agencies, and medical institutions were actively suppressing this knowledge. He framed his work as a fight against institutional corruption.

Important context: Simpson’s conspiratorial framing reflects a worldview shared by many in the early cannabis movement. In Chattooga County, where folks have watched the opioid crisis devastate communities while pharmaceutical companies made billions, that skepticism toward institutions resonates. We understand it. We’ve felt it too. But as a company committed to evidence, we also have to be honest: conspiracy theories don’t cure cancer. Science does. And the science shows that while RSO has real potential, the cancer cure claims are ahead of the evidence.

The Traditional RSO Protocol: What Chattooga County Needs to Know

Simpson’s core recommendation was a 60-gram oral protocol delivered over approximately 90 days. For someone in Chattooga County considering this approach, here’s exactly what that entails:

The 60-Gram Goal

Simpson considered 60 grams the minimum necessary for a serious cancer treatment course. That’s roughly 60 mL of extremely concentrated oil — an enormous amount of cannabis extract.

The Titration Schedule

• Week 1: Start with a dose the size of half a grain of dry rice — about 10-15 mg of oil — taken three times daily (morning, afternoon, before bed). That’s roughly 30-45 mg total per day.
• Weeks 2-5: Double the dose every four days. By the end of this period, target approximately 1 gram (1,000 mg) per day, divided into three doses.
• Weeks 5-12: Maintain 1 gram per day, divided into three doses of roughly 333 mg each, until all 60 grams are consumed.

How to Take It

• Oral: Simpson recommended sublingual (under the tongue) or swallowing as the primary method for internal cancers and systemic conditions.
• Topical: For skin cancers, apply directly to lesions, cover with a bandage, change every 3-4 days, and combine with oral dosing.
• Inhalation: Simpson didn’t recommend smoking or vaping as a primary treatment, though he acknowledged it could help with immediate symptom relief.

Tolerance and Psychoactive Effects

Simpson claimed patients would develop tolerance to THC’s psychoactive effects within 3-4 weeks. He urged patients not to let the “high” discourage them and recommended nighttime dosing initially to sleep through the worst effects. He warned against driving or operating machinery during titration — advice that’s just as relevant on the winding roads of Chattooga County as anywhere else.

Post-Protocol Maintenance

After completing 60 grams, Simpson recommended 1-2 grams per month indefinitely as a maintenance dose.

The Reality Check

This protocol was designed by one person based on personal experience. It was not developed through clinical trials, dose-finding studies, or formal research. Here are the critical issues:

• No controlled trial validation. None. Zero. Not even well-documented case series.
• Assumes crude, unstandardized material. The 60-gram quantity assumes a single-strain, THC-dominant extract with no standardized potency. Actual THC content varied wildly depending on the starting plant material and extraction technique.
• Extremely high THC exposure. At peak dosing, patients consumed roughly 1 gram of high-THC oil daily. Assuming 60-90% THC content, that’s 600-900 mg of delta-9 THC per day. For perspective, the FDA-approved synthetic THC drug dronabinol is typically dosed at 2.5 to 20 mg per day. That’s a 30 to 360-fold difference.
• Real risks at these doses. Consuming 600-900 mg of THC daily carries serious risks: severe intoxication, impairment, anxiety, panic, tachycardia, hypotension, cannabis use disorder. These aren’t theoretical — they’re well-documented in the safety literature.
• Oncology complexity. Cancer patients in Chattooga County are often medically complex. Using unregulated, unstandardized cannabis oil as a primary treatment — potentially instead of proven therapies — introduces harm that extends beyond the oil itself.

What Traditional RSO Actually Was

Understanding the original product helps Chattooga County residents evaluate what’s being sold today. Traditional RSO was defined by its method, not by lab specs.

Source Material: Simpson used high-THC indica-dominant strains. He grew his own or sourced from trusted growers. There was no strain standardization — the starting material varied by availability and growing season. If you’re buying “RSO” in Rome or Dalton today, it probably doesn’t match what Simpson made in Nova Scotia.

Extraction Solvent: Naphtha (a petroleum-based solvent) or 99% isopropyl alcohol. Neither is food-grade. Naphtha may contain benzene, toluene, and other toxic or carcinogenic compounds. Incomplete solvent purging — which is nearly impossible to verify without lab testing — leaves potentially harmful residues in the finished oil.

The Process:

1. Cannabis in a bucket
2. Cover with solvent, agitate to dissolve cannabinoids
3. Filter through cheesecloth
4. Repeat with fresh solvent
5. Evaporate solvent in a rice cooker at relatively low heat
6. Thick, dark oil remains
7. Transfer to oral syringes

This process destroyed terpenes and fully decarboxylated THCa into THC.

What It Looked Like: Nearly black, thick, tar-like, sticky oil with a strong cannabis odor and possible solvent-residual smell.

Cannabinoid Profile: THC-dominant (estimated 60-90%), with whatever minor cannabinoids the source strain contained at natural ratios. No ratio control. No lab verification. Every batch was different.

Terpene Content: Minimal to none. The solvent and heat process stripped them out.

Standardization and Testing: None. No COAs, no cannabinoid quantification, no contaminant screening.

Residual Solvent Risk: This is the deal-breaker. Naphtha and isopropyl alcohol are not food-grade. Incomplete purging means you could be consuming toxic residues. Modern extraction uses food-grade ethanol or supercritical CO₂ specifically to solve this problem.

Simpson’s Claims vs. The Evidence: What Chattooga County Deserves to Know

Simpson stated that RSO could cure cancer and many other diseases. He believed pharmaceutical companies, government agencies, and medical institutions were actively suppressing this knowledge. Let’s look at what the evidence actually shows.

What Simpson Was Not

He had no formal training in medicine, oncology, pharmacology, or clinical research. He never designed, conducted, funded, or published a clinical trial. He never submitted results to peer review. His entire evidence base was personal experience, self-reported patient outcomes, and testimonials gathered informally — with no controls, no independent verification, no imaging confirmation, no long-term follow-up, and no blinding.

What the Preclinical Literature Shows

The research does exist and it’s scientifically interesting:

• In vitro studies show THC and CBD can induce apoptosis (programmed cell death), inhibit proliferation, and reduce angiogenesis (blood vessel formation that feeds tumors) in certain cancer cell lines.
• Animal models show some tumor-growth inhibition in mice and rats treated with cannabinoids.
• These findings have generated legitimate scientific interest and ongoing research.

What the Preclinical Literature Does NOT Show

• These findings have NOT translated into proven human cancer cures. The gap between animal results and human clinical outcomes is vast.
• No human clinical trial has demonstrated that RSO or any cannabis oil preparation cures cancer.
• Several small human trials of cannabinoids in cancer contexts (particularly glioblastoma) have been conducted, but they were exploratory, small, and did not produce results that support cancer-cure claims.

What Institutions Say

• U.S. National Cancer Institute (NCI): Acknowledges cannabinoids have been studied for potential anticancer effects in lab and animal models but does not endorse cannabis or cannabis oil as a cancer treatment.
• U.S. Food and Drug Administration (FDA): Has not approved any cannabis plant product for cancer treatment. Only Epidiolex (CBD) for certain seizure disorders and dronabinol/nabilone (synthetic THC analogues) for chemo nausea and AIDS-related wasting are FDA-approved.
• Health Canada: Has never approved RSO or cannabis oil as a cancer cure.
• NCCIH: States the strongest cannabinoid evidence is for rare epilepsies, chemo nausea/vomiting, and HIV/AIDS appetite — not cancer cure.

What Simpson Got Right

He drew attention to cannabinoids as a serious biomedical research area when the world was ignoring it. His advocacy helped create the political, cultural, and social conditions for the legal cannabis industry and research infrastructure that exists today. He brought concentrated cannabis oil to widespread public awareness. The term “RSO” remains the most recognized name for full-spectrum cannabis extract. These contributions are real and historically significant.

What He Overstated

The leap from preclinical signals to cancer cure was not supported by human evidence then, and it’s not supported now. Encouraging patients — particularly cancer patients — to rely on RSO as a primary treatment instead of proven oncologic therapies carries genuine harm potential. Delayed or foregone treatment for treatable cancers is a documented concern. In Chattooga County, where we have limited oncologists and treatment centers, delaying proven care to try an unproven alternative can be catastrophic.

The Legacy: Why “RSO” Is Now a Generic Term

The term RSO is now used broadly and loosely across the legal cannabis industry. Many products labeled RSO bear little resemblance to what Simpson originally made. In dispensaries today, RSO can refer to almost any full-spectrum cannabis extract in a syringe format, regardless of extraction method, cannabinoid profile, terpene content, or intended use.

Simpson himself has been critical of commercial products that use the RSO name while departing from his original method and philosophy. He believed in a DIY, free-access model where anyone could grow cannabis, extract oil, and treat themselves without corporate intermediaries. He gave his oil away for free and urged others to make their own rather than buy from companies.

The modern cannabis industry took something free and made it commercial. Whether that’s an improvement (quality control, lab testing, dosing precision) or a betrayal (profit extraction, regulatory gatekeeping) depends on your perspective. The cannabis community remains divided.

What isn’t in dispute is that modern RSO has evolved substantially. And those changes directly solve the problems that limited Simpson’s original vision.

Traditional RSO vs. Modern Formulated RSO: A Chattooga County Comparison

Dimension	Traditional RSO	OilWell Formulated RSO
Source Material	Single high-THC indica strain	Multi-cannabinoid blend from multiple sources
Extraction Method	Naphtha or isopropyl alcohol	Modern food-grade ethanol or CO₂ methods
Cannabinoid Profile	THC-dominant, uncontrolled	Seven defined cannabinoids at specific ratios
Terpene Content	Destroyed by high-heat process	Live terpenes at 5% with defined seven-terpene profile
Standardization	None — every batch different	Lab-tested with specific mg/mL targets
Lab Testing	Not available or performed	Full panel testing (potency, terpenes, pesticides, heavy metals, residual solvents, microbial)
Residual Solvents	Significant risk with naphtha	Controlled and tested (solvent-free)
Dosing Precision	Approximate, syringe-based	Measured per mL with known cannabinoid content (553 mg/mL)
Product Formats	Single thick oil only	Sublingual oil and vape cartridge with format-specific formulas
THCa Preservation	No — fully decarboxylated by heat	Yes — THCa included as separate ingredient at 1,500 mg
Evidence Approach	Anecdotal, personal testimony	Research-backed, evidence-weighted

Why OilWell’s Formulas Diverge From Traditional RSO

Our divergence isn’t arbitrary — it’s deliberate and evidence-motivated:

Multi-Cannabinoid Approach: Traditional RSO relied on whatever single strain the maker grew. Our formulas intentionally include seven cannabinoids — CBD, CBG, delta-8 THC, THCa, delta-9 THC, CBN, and CBC — because the entourage-effect literature suggests potential benefit from cannabinoid diversity, even though robust clinical proof of whole-formula synergy remains limited.

Terpene Preservation: Traditional RSO had essentially no terpene content. We include live terpenes at 5% with a specific seven-terpene profile because terpene bioactivity is plausible and supported at the preclinical level, even if human clinical confirmation for cannabis-specific terpene effects is still developing.

THCa as Separate Ingredient: Traditional RSO fully decarboxylated everything. Our sublingual formula includes THCa at 1,500 mg as a distinct ingredient, preserving the acidic precursor because the THCa literature suggests potentially relevant non-psychoactive bioactivity that is lost when THCa converts to THC.

Reduced Delta-9 THC Dominance: Traditional RSO was 60-90% delta-9 THC. Our formula uses delta-9 THC at only 90 mg while distributing the remaining cannabinoid content across CBD, CBG, delta-8 THC, CBN, and CBC — reflecting the broader cannabinoid research landscape rather than a single-compound dominance model.

Product Format Innovation: Simpson envisioned only one format: oral oil from a syringe. We offer both a 30 mL sublingual oil and a 1-gram vape cartridge, each with its own format-specific formulation acknowledging that different delivery routes have different pharmacokinetic profiles.

The Origin of OilWell Cannabis: A Story That Resonates in Chattooga County

OilWell Cannabis was founded by Colin Valencia in Houston, Texas. But Colin’s story didn’t start in Texas — it started in McAllen, Texas, right across the river from Reynosa, Tamaulipas, Mexico. The McAllen-Reynosa area, known as the Borderplex, is one of the most economically challenged and dangerous regions along the U.S.-Mexico border. It’s a place of contrasts — vibrant culture but limited opportunities, industrial hub but plagued by violence. A place where you learn to hustle early, where you see friends killed or imprisoned, where you leave home at sixteen because staying isn’t an option.

Despite the dangers, Colin didn’t fall into harder substances. He focused on cannabis, seeing it as a safer alternative. He grew up in the traditional cannabis world long before legalization, learning the plant intimately while operating in the shadows. Over time, he transitioned from those early risky ventures to creating a legal, legitimate business in an industry he believes in.

Colin later became a formally trained software engineer and did custom development work for Baylor College of Medicine — one of the most prestigious medical institutions in the Texas Medical Center. That combination of deep cannabis plant knowledge and medical-grade technical precision defines everything OilWell does.

But the company’s origin story doesn’t begin with a business plan. It begins with a dog named Bentley.

Bentley: The Heart of Our Mission

Bentley was more than a pet — he was family. When Bentley fell seriously ill and veterinarians delivered the verdict no pet owner wants to hear (euthanasia was the only humane option), Colin refused to accept it. Bentley was paralyzed in his back legs. The vets said pain medications would destroy his internal organs, causing more suffering. The choice was painful prolonged decline or immediate mercy killing.

But giving up wasn’t an option. In a desperate search for alternatives, Colin stumbled upon CBD through a question that changed everything. A rescue worker named Jessica asked: “You’ve moved how many tons of weed and you’ve never heard of CBD?”

Colin had cannabis experience — but it was recreational. Getting high. He’d never explored therapeutic applications. Jessica’s question exposed a blind spot that became a mission.

Determined to save Bentley, Colin learned to create CBD golden paste — a specialized cannabinoid formula for pets. It wasn’t a cure, but it was a lifeline. And that hope delivered something veterinary medicine said was impossible: Bentley got up. He walked over and brought Colin his ball to play. From paralyzed and facing euthanasia to fetching his ball.

Dogs don’t respond to placebo. This was cannabinoid medicine doing what pharmaceuticals could not.

Bentley lived another ten years, passing naturally at age twenty. During those years, Colin developed specialized cannabis formulas for every age-related condition Bentley faced:

• Neurodegeneration → Understanding CBG’s neuroprotective properties and THCa’s PPARγ agonism for brain cell protection
• Dementia → Learning CBC’s role in neurogenesis
• Glaucoma → Discovering THC’s CB1 agonism for intraocular pressure reduction
• Crippling arthritis → Developing multi-pathway anti-inflammatory approaches using CBD, CBG, THCa, and beta-caryophyllene working through different receptor systems simultaneously

Single cannabinoids were not enough. Bentley’s evolving conditions required multi-cannabinoid synergy. CBD alone couldn’t address neurodegeneration and dementia and glaucoma and arthritis simultaneously. Minor cannabinoids became critical. Pharmaceutical precision mattered — Bentley’s life depended on formula accuracy, not guesswork.

Bentley’s journey was Colin’s entry into cannabis beyond just getting high. It became a mission to create real solutions that alleviate pain and suffering — not just for pets, but for people. Bentley’s story is the foundation of OilWell Cannabis, driving our commitment to quality, innovation, and compassionate care.

Colin’s Personal Battle: PTSD, Benzo Addiction, and the Birth of Peace

Colin also knows pharmaceutical dependence personally. He struggled with PTSD and benzodiazepine addiction. When he decided to break free from Xanax, he did it cold turkey — notoriously difficult and dangerous — using the cannabinoid knowledge he developed keeping Bentley alive.

The Peace Gummies formula that became an OilWell product was created during midnight experiments while fighting through benzo withdrawal. To ensure quick relief, Colin also offers Peace Gummies in vape form, which he personally uses to manage his insomnia and severe PTSD. This isn’t theoretical knowledge. Colin lived what RSO patients live: desperation for relief, failed pharmaceuticals, the discovery that cannabinoids work when pills do not.

That personal experience transforms our credibility. We’re not just selling products — we’re sharing what saved us. What saved Bentley. What helps Colin sleep at night without benzodiazepines.

Why Chattooga County Matters to Us

Over time, the therapeutic benefits Colin discovered through Bentley became the core of his work. He has developed formulas that doctors use for conditions like Crohn’s disease, IBS, ulcerative colitis, PTSD, benzo addiction, and insomnia. His focus has always been on making cannabis accessible and effective for everyone, including vegans, diabetics, and those with specific health needs.

ABC13 KTRK Houston — Houston’s number-one news source — featured Colin and OilWell Cannabis in seven comprehensive news segments spanning 2019 to 2023. Colin was repeatedly selected as the primary industry expert for cannabis policy and product coverage in America’s fourth-largest city. When reporters needed someone who would tell the truth, they called Colin.

That same commitment to truth is what we’re bringing to Chattooga County. We’re not here to sell you hope. We’re here to give you the best possible version of the information so you can decide for yourself whether it’s right or wrong for you.

The OilWell RSO Philosophy: Four Principles for Chattooga County

OilWell’s RSO is not traditional RSO. It’s a formulated, multi-cannabinoid product informed by the tradition but departing from it in deliberate, evidence-motivated ways that solve problems Simpson’s approach couldn’t address.

1. Accessibility Over Gatekeeping

No medical card required. Anyone age twenty-one or older can purchase. We ship nationwide across the United States and internationally to customers who verify local legality.

In Georgia, the medical cannabis program (TCUP) is one of the most restrictive in the country. You need a qualifying condition, a doctor’s recommendation, and you can only purchase from a handful of dispensaries. For someone in Chattooga County, that means driving all the way to Macon, Columbus, or Marietta — hours away — just to access limited, THC-only products.

We built a product and distribution model that makes RSO accessible legally without those barriers. You can order from your home in Lyerly or Trion and have it delivered directly. No medical card. No qualifying condition. No three-hour drive to the nearest dispensary.

2. Patient-Controlled Potency

THCa is sold in its acidic, non-psychoactive form. YOU decide whether to use it raw for non-psychoactive benefits or to decarboxylate it into delta-9 THC for full psychoactive potency.

This matters in Chattooga County. If you work at the rug mill in Trion, you can’t show up impaired. If you’re farming the beautiful land that defines our county, you need to operate equipment safely. If you’re caring for grandchildren, you need to be present and alert. Our raw THCa option gives you anti-inflammatory benefits with zero impairment.

But if you’re facing cancer and want the full psychoactive experience Simpson described, you can decarboxylate at home and achieve that potency legally and safely. The control is yours.

3. Open-Source Formulas

We publish our complete formulas publicly — every cannabinoid, every milligram amount, every percentage. If you can’t afford our products, you can see exactly what they contain, source the individual cannabinoid distillates and isolates, and make your own version.

This is a direct echo of Rick Simpson’s original ethos. He gave his oil away for free and taught people how to make it. He never patented his method. He never charged patients. We’ve adapted that ethos for the modern cannabinoid marketplace: we sell a professionally manufactured, lab-tested, standardized product for those who want it, and we publish the complete recipe for those who want to make it themselves.

The Bentley Recipe: Our Original Open-Source Formula

Before we published the RSO formulas, we published the CBD golden paste recipe that saved Bentley’s life. Here it is, free for any Chattooga County pet owner facing a similar crisis:

Ingredients:

• 1/2 cup organic turmeric powder
• 1 cup water
• 1/3 cup coconut oil (unrefined, organic)
• 1 to 2 teaspoons freshly ground black pepper (important for absorption)
• CBD oil (dosage depends on pet size; consult a veterinarian)

Instructions:

1. Mix turmeric and water in a saucepan over low heat, stirring continuously until thick paste forms (7-10 minutes)
2. Add coconut oil and pepper, stir thoroughly
3. Cool, store in refrigerator up to two weeks
4. Add CBD oil before giving to pet, adjusting dosage by weight
5. Mix with pet’s food once or twice daily, monitoring for changes

This recipe demonstrates that our open-source pattern is foundational behavior, not marketing strategy. We gave away the formula that saved Bentley before we gave away the formula for people.

4. Evidence-Informed, Not Evidence-Overstating

The GENERAL KNOWLEDGE section in this document represents our commitment to honest education about what science actually says. Simpson operated without access to peer-reviewed literature or clinical trial data. We have that access and use it to distinguish between what is well-supported, what is emerging, and what is overstated.

When we make specific research claims about individual cannabinoids or terpenes, we provide the source evaluation context — the same peer-reviewed citations, the same evidence-tier assessments, and the same cautious interpretation framework. We don’t exempt ourselves from the evidence standards we apply to the broader field.

Farm Bill Compliance and Why It Matters for Georgia

The 2018 Farm Bill (Agricultural Improvement Act) legalized hemp and hemp-derived products containing less than 0.3% delta-9 THC by dry weight at the federal level. This is the legal foundation that makes our RSO product possible.

Our RSO Sublingual Oil contains only 90 mg of delta-9 THC in the entire 30 mL bottle — that’s 3 mg per mL, well under the 0.3% threshold. All cannabinoids in our formula are hemp-derived. The product is legal under federal law and in Georgia.

Why THCa Changes Everything

THCa (tetrahydrocannabinolic acid) is the acidic, non-psychoactive precursor to delta-9 THC. At the point of sale, THCa is Farm Bill compliant because it has not been converted to delta-9 THC.

You can decarboxylate THCa into delta-9 THC at home by heating the oil at 260°F (125°C) for 45-60 minutes in an oven-safe glass container. This converts 1,500 mg of THCa into approximately 1,315 mg of delta-9 THC. Combined with the existing 90 mg of delta-9 THC, you get approximately 1,405 mg of total delta-9 THC — giving the product psychoactive potency comparable to traditional illegal RSO, entirely at your discretion after purchase.

This means the same product can function as a non-psychoactive anti-inflammatory (used raw) or as a full-potency psychoactive cannabinoid product (after home decarboxylation). You control the decision.

Legal Notice for Chattooga County Residents: THCa converts to delta-9 THC when heated. You are responsible for understanding and complying with Georgia law regarding cannabinoid products. We ship with full documentation, Certificates of Analysis, and receipts. Georgia law permits hemp-derived products with less than 0.3% delta-9 THC. Our product meets this standard at the point of sale. Any conversion you perform at home is your decision and responsibility.

Solvent-Free Production: Safety First

Traditional RSO production used naphtha or isopropyl alcohol — neither food-grade. Naphtha is a complex petroleum hydrocarbon mixture that may contain benzene, toluene, and other toxic compounds. Incomplete solvent purging is very difficult to verify without lab testing and leaves potentially harmful residues in the finished oil.

We don’t extract that way. Our RSO is a formulated blend of individual cannabinoid distillates and isolates combined at specific ratios in a controlled production environment. No naphtha. No isopropyl alcohol. No butane. No extraction solvents in the finished product.

We use organic MCT oil (medium-chain triglycerides) as the carrier base. MCT oil is a food-grade lipid carrier that facilitates cannabinoid absorption through sublingual tissue and provides a neutral taste profile — a major improvement over the tar-like consistency and solvent-residual odor of traditional RSO.

Every batch undergoes third-party lab testing covering:

• Cannabinoid potency
• Terpene profile
• Pesticides (400+ compound screening)
• Heavy metals (arsenic, cadmium, lead, mercury)
• Residual solvents (FDA Class 3 limits <5,000 ppm)
• Microbial contaminants (E. coli, Salmonella, Aspergillus)

Certificates of Analysis (COAs) are available on request and accessible through our website.

Our Products: The Complete Chattooga County Guide

We offer the RSO formula in two delivery formats, each designed for different use cases.

RSO Sublingual Oil — $129.99

Specs:

• 30 mL bottle (1 fl oz)
• 16,590 mg total cannabinoids (553 mg per mL)
• Seven cannabinoids: CBD 4,500 mg, CBG 3,000 mg, delta-8 THC 6,000 mg, THCa 1,500 mg, delta-9 THC 90 mg, CBN 750 mg, CBC 750 mg
• Live terpenes at 5%: limonene, myrcene, caryophyllene, pinene, linalool, humulene, terpinolene
• Organic MCT oil base
• Graduated dropper for precise dosing in 0.1 mL increments

Pharmacokinetics:

• Onset: 15-45 minutes (sublingual absorption)
• Peak effects: 1-2 hours
• Duration: 4-6 hours
• Bioavailability: 13-19% (partially bypasses first-pass liver metabolism)
• Approximately 40-60 doses per bottle depending on serving size

RSO Vape Cartridge — $49.99

Specs:

• 1-gram cartridge
• 900 mg+ total cannabinoids
• Same six-cannabinoid ratio as sublingual (auto-decarboxylates THCa at vaping temperature)
• Live terpenes at 5%+
• 510-thread universal battery compatibility

Pharmacokinetics:

• Onset: 1-2 minutes (fastest cannabinoid delivery)
• Peak effects: 10-15 minutes
• Duration: 2-4 hours
• Bioavailability: 10-35% (depends on inhalation technique)
• Automatic THCa decarboxylation at 400-450°F

Condition-Specific Usage Context for Chattooga County

Important Disclaimer: The following contexts are informed by cannabinoid research and our formulation rationale. They are NOT medical prescriptions, NOT FDA-approved treatment protocols, and NOT a substitute for professional medical care. These products have not been evaluated by the FDA and are not intended to diagnose, treat, cure, or prevent any disease. Always consult a qualified healthcare provider before using cannabinoid products, especially if you have a medical condition, are taking medications, are pregnant or nursing, or have any health concerns. Do not operate vehicles or machinery while under the influence of psychoactive cannabinoids.

Chemotherapy-Related Nausea and Appetite Support

For Chattooga County residents traveling to Erlanger Cancer Center in Chattanooga or cancer centers in Atlanta for treatment, this matters:

• Pre-chemo: 0.5-1.0 mL sublingual approximately 1 hour before treatment
• Acute breakthrough nausea: 2-3 vape puffs for immediate relief (1-2 minute onset)
• Post-chemo: 0.5 mL sublingual every 6 hours as needed
• Sleep support during treatment: 1.0-2.0 mL sublingual before bed (delivers 25-50 mg CBN)

Evidence: delta-8 THC antiemetic evidence, delta-9 THC nausea/vomiting evidence, CBD anxiolytic buffering

Chronic Pain (Fibromyalgia, Arthritis, Neuropathy)

For the many Chattooga County residents who’ve worked physically demanding jobs:

• Daytime: 0.3-0.5 mL raw sublingual — provides anti-inflammatory cannabinoid exposure without psychoactive impairment (crucial if you’re operating farm equipment or driving Highway 27)
• Nighttime: 0.5-1.0 mL decarboxylated sublingual — combines pain relief with CBN sleep support
• Breakthrough pain: Vape as needed for rapid onset

Evidence: CBD pain evidence, delta-9 THC pain evidence, beta-caryophyllene CB2 agonism, THCa COX-2 inhibition

Sleep Support

• Before bed: 1.0-2.0 mL sublingual
• At 2.0 mL, this delivers 50 mg CBN — the dosage investigated in 2024 sleep literature
• At 1.0 mL, this delivers 25 mg CBN — above the threshold associated with reduced sleep disturbance

Evidence: CBN sleep evidence, cannabis and sleep review literature

Anxiety and Stress

• Daytime functional relief: 0.3 mL raw sublingual — CBD and CBG address anxiety without impairment
• Nighttime: 1.0 mL sublingual — full profile including CBN for sleep architecture

Evidence: CBD anxiety evidence, CBG pharmacology, limonene entourage-effect evidence

General Titration Principle for Chattooga County

Start low, go slow. Begin with 0.25-0.5 mL sublingual and assess effects over 2-3 hours before increasing. Individual responses vary based on body weight, metabolism, tolerance, concurrent medications, and other factors. This is especially important if you’re taking other medications common in older populations in Chattooga County.

Getting OilWell RSO in Chattooga County: Delivery & Access

We ship nationwide to all 50 states where Farm Bill-compliant products are legal — including Georgia. For Chattooga County residents, this is game-changing. You don’t need to drive to Atlanta or Macon. You don’t need a medical card. You can order from your home in Menlo or Sharon and have it delivered directly.

Shipping to Chattooga County:

• USPS Priority Mail (2-3 business days)
• FedEx and UPS Ground (3-5 business days)
• Discreet packaging with no cannabis branding visible
• Tracking provided for all orders
• Temperature-stable packaging for Georgia summers
• Signature-required option available

International Shipping: We also ship internationally to jurisdictions with compatible hemp laws, with full documentation and COAs for customs.

The Chattooga County Advantage: While Georgia’s medical cannabis program remains one of the most restrictive in the country (only about 10,000 active patients statewide compared to Florida’s 700,000), our Farm Bill-compliant products bypass those restrictions entirely. You get access to seven cannabinoids, not just THC. You get precision dosing, not guesswork. You get lab-tested safety, not backyard chemistry.

The Decarboxylation Choice: Your Power, Your Potency

This is where our product fundamentally differs from everything else on the market — and it’s particularly relevant for Chattooga County’s diverse needs.

Three Usage Options from One Product:

Option 1: Raw, No Heat (Non-Psychoactive)

All 1,500 mg stays as THCa — completely non-psychoactive. The THCa evidence shows potential anti-inflammatory activity via COX-2 inhibition and neuroprotective potential via PPARγ agonism. This is perfect for Chattooga County residents who need to work, drive, or function during the day with zero impairment.

Option 2: Fully Activated, Home Decarboxylation

Heat the oil at 260°F (125°C) for 45-60 minutes in an oven-safe glass container. This converts 1,500 mg THCa into approximately 1,315 mg delta-9 THC. Combined with the existing 90 mg delta-9 THC, you get ~1,405 mg total delta-9 THC — achieving psychoactive potency comparable to traditional illegal RSO, 100% legally, because decarboxylation occurs at your discretion after purchase.

You can even decarboxylate only a portion: transfer some oil to a second container, heat only what you intend to use, and preserve the remainder in raw THCa form.

Option 3: Vape (Auto-Decarboxylation)

The RSO Vape Cartridge vaporizes at 400-450°F, instantly converting THCa to delta-9 THC with each puff. Every inhalation delivers freshly decarboxylated cannabinoids — the fastest RSO delivery method available.

The Chemistry: THCa has a molecular weight of 358.47 g/mol. The conversion ratio is approximately 1 mg THCa = 0.877 mg delta-9 THC after decarboxylation, reflecting the loss of a CO₂ molecule.

This design puts the potency decision entirely in your hands — aligning with Rick Simpson’s principle that patients should control their own medicine, but implementing it through actual product chemistry rather than rhetoric.

When to Use Each Format: A Chattooga County Decision Guide

Use Case	Recommended Format	Why It Works
Fast relief (acute pain, nausea, panic)	Vape	1-2 minute onset
Sustained relief (chronic pain, sleep)	Sublingual	4-6 hour duration
Maximum bioavailability	Sublingual	13-19% absorption
Portability/discretion	Vape	Compact, no measuring
Precise dosing control	Sublingual	Graduated dropper in 0.1 mL increments
Daytime non-psychoactive use	Sublingual (raw)	THCa stays inactive, zero impairment
Nighttime psychoactive use	Sublingual (decarbed) or Vape	Activated THCa + delta-8 THC

For Chattooga County residents who might need relief during a church service or community event: the vape offers discretion. For those managing chronic conditions throughout the day: the sublingual oil provides sustained control. For farmers who can’t be impaired while working their land: the raw option delivers benefits without psychoactivity.

Competitive Comparison: Why OilWell Stands Out in Georgia

OilWell RSO vs. Texas TCUP Dispensary RSO

Georgia’s medical program is even more restrictive than Texas’s, but the comparison holds:

Dimension	Georgia Medical Program (If It Were Similar to TCUP)	OilWell RSO
Cannabinoid profile	THC-only	7 cannabinoids
Patient-controlled potency	No — always psychoactive	Yes — THCa stays raw until you decide
Access requirements	Qualifying condition + doctor + card	Age 21+ only
Delivery	Travel to dispensary (hours away)	Ships to your door in Chattooga County
Legal framework	State medical program	Farm Bill compliant

OilWell RSO vs. Hemp CBD RSO (e.g., Lazarus Naturals)

Dimension	Typical Hemp CBD RSO	OilWell RSO
Total cannabinoids	1,000 mg	16,590 mg
CBD content	~950 mg	4,500 mg
CBG content	15.5 mg	3,000 mg
CBN content	0.7 mg	750 mg
Delta-8 THC	0 mg	6,000 mg
THCa (convertible)	Minimal	1,500 mg
Psychoactive option	No	Yes
Price	$40-50	$129.99

The Science Behind Every Cannabinoid: Evidence for Chattooga County

We believe you deserve to know exactly what the research says — not marketing hype. Here’s what the evidence shows for each compound in our formula:

CBD (4,500 mg in sublingual oil)

Strongest evidence: Seizure disorders (Epidiolex is FDA-approved for certain rare epilepsies) [1][2]

Anxiety: A 2024 systematic review and meta-analysis covering 316 participants across eight studies found a statistically significant anxiolytic signal, but authors stress the clinical sample remains limited and more trials are needed [3].

Pain: A 2024 systematic review of clinical and preclinical CBD monotherapy studies concluded the pain literature is promising but heterogeneous, with trial quality still limiting confidence in broad analgesic claims [4].

Sleep: A 2023 insomnia review found the literature remains methodologically weak, with many studies relying on nonvalidated subjective measures [5].

Safety: A 2023 systematic review and meta-analysis found a real signal for liver enzyme elevation and possible drug-induced liver injury, especially relevant for concentrated oral products and polypharmacy settings [6]. NCCIH also flags diarrhea, sleepiness, appetite changes, mood effects, and drug-drug interactions [1].

Bottom line: CBD is the most evidence-developed nonintoxicating cannabinoid, but strong evidence is concentrated in specific indications rather than broad wellness claims.

CBG (3,000 mg in sublingual oil)

Evidence profile: Mostly review-level and preclinical; human evidence remains sparse [7][8].

Pharmacology: CBG is the biosynthetic precursor to several major cannabinoids with distinct pharmacology from THC and CBD, interacting with cannabinoid receptors, alpha-2 adrenoceptors, and 5-HT1A signaling [7].

Research areas: Reviews discuss possible relevance to neurologic disorders, inflammatory bowel disease, and antibacterial activity, but these are primarily pharmacology-led hypotheses rather than mature human conclusions [7][8].

Caution: The 2021 pharmacology review notes CBG is already being sold commercially while the evidence base remains thin — claims frequently outrun science [7].

Bottom line: CBG is a promising minor cannabinoid with limited clinical validation [7][8].

Delta-8 THC (6,000 mg in sublingual oil)

Evidence profile: Pharmacologically relevant and psychoactive, much less clinically characterized than delta-9 THC [9]-[11].

Comparative pharmacology: A 2022 review concluded delta-8 THC and delta-9 THC have broadly similar pharmacokinetic and pharmacodynamic behavior. Delta-8 is a partial CB1 agonist with cannabimimetic activity, but appears less potent than delta-9 THC, likely due to weaker CB1 affinity [9].

Public health: A 2023 scoping review found the delta-8 evidence base dominated by animal studies, product chemistry, use reports, and public-health concerns rather than strong modern human trials. It noted reports of adverse consequences and emphasized regulatory and product-quality concerns [10].

Manufacturing: The chemistry review reinforces that commercial delta-8 interest is tied to greater stability and easier synthesis relative to naturally scarce plant levels, which raises product-byproduct and lab-testing questions [11].

Bottom line: Delta-8 THC is a psychoactive THC analogue with real pharmacologic activity, incomplete human safety characterization, and more manufacturing-quality uncertainty than many consumers realize [9]-[11].

THCa (1,500 mg in sublingual oil)

Evidence profile: Important chemically and formulation-wise, but low on direct human therapeutic evidence [12].

What it is: THCa is the acidic precursor of THC and may represent a large share of THC-related content in raw plant material. It decarboxylates into THC during heating and can change over time during storage and processing [12].

Psychoactivity: THCa itself does not produce psychoactive effects associated with THC, but this only holds if the molecule stays acidic and isn’t substantially decarboxylated [12].

Research status: In vitro and rodent literature suggest anti-inflammatory, immunomodulatory, neuroprotective, and antineoplastic possibilities, but these are not equivalent to established human outcomes [12].

Bottom line: THCa is best understood as a highly relevant precursor whose interpretation depends heavily on route, temperature, processing, and storage [12].

Delta-9 THC (90 mg in sublingual oil)

Evidence profile: Strongest human evidence of the psychoactive cannabinoids, but also the clearest adverse-effect burden [1][13]-[15].

Institutionally supported uses: NCCIH identifies THC-containing medicines as relevant to chemo-related nausea/vomiting, HIV/AIDS appetite/weight loss, and some MS- and pain-related outcomes, while stressing many other uses remain uncertain [1].

Pain evidence: A 2022 systematic review found cannabis-based products with high THC content or comparable THC:CBD ratios may provide short-term pain benefit but increase dizziness, sedation, nausea, and treatment discontinuation [13].

Pharmacokinetics: Inhaled THC: effects within seconds to minutes, peak in 15-30 minutes, taper over a few hours. Oral THC: later onset, later peak, longer duration [14].

Mental health risk: A 2025 systematic review of high-concentration THC products found consistent unfavorable associations with psychosis/schizophrenia outcomes and cannabis use disorder, with concerning signals for anxiety and depression [15].

Broader safety: Anxiety/panic at high doses, tachycardia, blood pressure changes, dependency potential, withdrawal symptoms, pregnancy concerns, accidental pediatric exposure, vape-related lung injury [1][14][15].

Bottom line: Delta-9 THC has legitimate therapeutic relevance but carries the clearest intoxication, psychiatric, and dose-related safety liabilities [1][13]-[15].

CBN (750 mg in sublingual oil)

Evidence profile: Weak human evidence; marketing has moved ahead of data [12][16][17].

Marketing vs. reality: Widely marketed for sleep/sedation, but clinical support is far thinner than the market suggests [16][17].

Sleep claim review: A 2021 narrative review screened 99 human-study abstracts and reviewed 8 full-text articles, finding NO clinical trials using validated sleep questionnaires or formal polysomnography that could substantiate strong sleep-promoting claims for CBN [16].

Broader sleep literature: A 2024 updated review concluded cannabis sleep research still doesn’t match real-world use scale, and need for better-designed trials remains substantial [17].

Chemical context: THC can degrade toward CBN under certain conditions, explaining why CBN is often discussed in aging/oxidized cannabis contexts [12].

Bottom line: CBN is one of the clearest examples where cultural reputation is stronger than current clinical evidence [16][17].

CBC (750 mg in sublingual oil)

Evidence profile: Emerging, intriguing, overwhelmingly preclinical or review-based [18][19].

Pharmacology: A 2024 focused review argues CBC has distinct pharmacodynamics, pharmacokinetics, and receptor behavior relative to better-known cannabinoids, highlighting antinociceptive, antibacterial, and anti-seizure areas as especially interesting [18].

Older literature: Review literature reports anti-inflammatory effects, reduced gut hypermobility, modest rodent analgesic activity, and possible neurobiological/antiproliferative relevance, but these aren’t strong patient-facing claims [19].

Safety caveat: The 2024 CBC review explicitly notes over-the-counter CBC products are already being sold despite little evidence establishing clinical efficacy or safety [18].

Bottom line: CBC is scientifically credible but clinically immature [18][19].

The Terpene Story: What Chattooga County Should Know

Terpene claims need even stricter interpretation than cannabinoid claims. Much literature comes from isolated compounds, essential oils, non-cannabis plants, or preclinical models. Robust proof of clinically meaningful entourage effects in humans remains limited [20][29].

Our seven-terpene profile (same for both products):

Limonene (citrus-bright)

• Evidence: Largely review and preclinical [20]-[22]
• Potential: Antioxidant, anti-inflammatory, cardioprotective, gastroprotective, immune-modulatory [21]
• Safety note: Limonene oxidation products (hydroperoxides) are clinically relevant contact allergens [22]
• Chattooga County connection: If you’ve ever peeled a fresh Georgia orange or lemon, you’ve smelled limonene. It’s the same molecule.

Myrcene

• Evidence: Mostly preclinical, very limited human evidence [20][23]
• Potential: Anxiolytic, antioxidant, anti-inflammatory, analgesic [23]
• Caution: Claims myrcene reliably causes sedation or “couch-lock” are stronger than human evidence supports [23]

Caryophyllene (β-caryophyllene) — pepper/spice

• Evidence: Among most mechanistically interesting due to CB2 receptor agonism, but still preclinical [24]
• Why it stands out: Selective CB2 receptor agonist — unusual and pharmacologically relevant [24]
• Research: Anti-inflammatory, immunomodulatory, antioxidant, neuroprotective, gastroprotective [24]

Pinene (forest-fresh)

• Evidence: Promising preclinical, weak human confirmation [20][25]
• Potential: Antioxidant, anti-inflammatory, neuroprotective [25]
• Caution: Claims pinene reliably improves memory or counterbalances THC cognitive effects remain hypotheses, not settled facts [25]
• Chattooga County connection: Walk through the pine forests around Cloudland Canyon and you’re breathing pinene.

Linalool (floral, lavender)

• Evidence: Substantial preclinical interest, limited direct clinical confirmation [20][22][25][26]
• Potential: Stress, mood, brain-health pharmacology [25][26]
• Safety: Oxidized linalool hydroperoxides are recognized allergens [22]

Humulene (earthy, woody)

• Evidence: Translationally interesting, early stage [20][27]
• Findings: 2024 scoping review of 340 articles found broad preclinical evidence for anti-inflammatory effects, some rodent work suggesting cannabimimetic properties via CB1 and adenosine A2a pathways [27]

Terpinolene (piney, fruity, sparkling)

• Evidence: Among least clinically characterized [20][28]
• Findings: 2021 systematic review of 57 studies concluded terpinolene has reported biological effects but evidence base dominated by in silico, in vitro, and animal studies [28]

Common Overstatements to Avoid: Chattooga County Education

We’d rather you be an informed consumer than a misled customer. Here are claims we see competitors make that go beyond the evidence:

Overstatement: CBN is a clinically proven sleep cannabinoid.
More Accurate: The specific sleep evidence for CBN remains weak and dated, with no strong validated-trial base yet identified [16][17].

Overstatement: Myrcene is a proven human sedative that causes couch-lock.
More Accurate: Myrcene has plausible preclinical bioactivity, but direct human proof for that common claim is limited [20][23].

Overstatement: Terpenes in general have proven entourage effects in patients.
More Accurate: Entourage hypotheses are influential and worth studying, but robust clinical proof remains limited and highly compound-specific [20][29].

Overstatement: THCa is always non-psychoactive.
More Accurate: THCa itself is not THC, but heating and processing can convert THCa into THC, changing effective exposure [12].

Overstatement: Delta-8 THC is safe because it’s hemp-derived.
More Accurate: Delta-8 THC is psychoactive, pharmacologically close to delta-9 THC, and often entangled with manufacturing and testing concerns [9]-[11].

Practical Takeaways for Chattooga County

1. CBD and delta-9 THC are the most evidence-developed actives in these formulas.
2. Delta-8 THC is not a trivial ingredient — it’s psychoactive with less robust safety characterization than delta-9 THC.
3. THCa meaningfully changes with processing — raw vs. heated vs. vaped are different products pharmacologically.
4. CBG, CBN, and CBC are scientifically credible but clinically immature compared to CBD and THC.
5. Terpene claims should be careful — they’re likely relevant to aroma/flavor and possibly some biologic activity, but compound-specific human therapeutic claims should be conservative.

Media Recognition: Why ABC13 Houston Keeps Coming Back

Between September 2019 and April 2023, ABC13 Houston featured Colin Valencia and OilWell in seven distinct news segments. Five different reporters sought us out across those years. Why? Because when they need someone who tells the truth about cannabis, who understands both the science and the street, who has lived experience with the plant and the legal system, they call us.

The Through-Line of Our Media Record:

Consistency across years: We appeared in 2019, 2021 (four times), 2022, and 2023. Through every shift in the cannabis landscape, ABC13 returned to us as a primary source.

Breadth of expertise: Features spanned business reporting, consumer health education, product investigation, legal analysis, political commentary, and community health advocacy.

Community action: The COVID vaccine giveaway — $35,000 in product, coordination with city government, no political strings — is documented evidence of our community-first philosophy. So was proactively removing Delta-8 products and warning other operators before enforcement began.

Personal stakes: In October 2022, Colin revealed he has a personal marijuana conviction history. That transforms the entire record — every quote about therapy, education, not selling snake oil carries additional weight when you understand the person saying it has personally experienced cannabis criminalization.

Evolution of language: In 2019, ABC13 called us “a local wholesaler.” By 2023, Colin was explaining industry dynamics and legal strategy on camera with the confidence of a sector leader.

This is the kind of recognition that cannot be purchased — it can only be earned.

The Complete Colin Valencia Quote Index

These 13 quotes, captured across four years of ABC13 features, tell our story better than any marketing copy:

“I’m not trying to sell people snake oil. I’m not trying to sell people hope, but there’s enough research out there that people just need to know and try and have the best possible version to base their opinions off of to give it a fair shot as to whether it’s right or wrong for them.” — September 2019

“Pain comes in a lot of different forms.” — March 2021

“I don’t give a sh* if it’s wrong to say you’ll get high off it. Maybe you want to get high.”* — May 2021

“We just want Houston to be as healthy as possible. We’re not doctors. We’re not experts on this . We don’t have any political agenda. Come and participate if it’s right and safe for you and your loved ones!” — August 2021

“I would love to see people not get hurt for this anymore.” — October 2022

“Right now is actually a pretty – like Renaissance – pretty important time that should be enjoyed now.” — April 2023

Our Promise to Chattooga County

OilWell Cannabis is more than a brand — it’s a promise that we will always strive to deliver the best, most thoughtful cannabis products available. We’re not here to follow trends. We’re here to set them through integrity, creativity, and the mission that started when Bentley got up, walked across the room, and brought his ball to play.

For Chattooga County residents facing cancer, chronic pain, PTSD, insomnia, or any of the conditions that have led you to research RSO: you deserve honesty. You deserve quality. You deserve access. You deserve control.

We can’t promise cures. No ethical company can. But we can promise this: every cannabinoid in our formula has been selected based on the best available evidence. Every milligram amount is published transparently. Every product is lab-tested for safety. And every customer in Chattooga County — whether you’re ordering for the first time or the twentieth — receives the same level of respect, education, and support.

Contact us:

• Phone: (832) 416-2816
• Email: [email protected]
• Website: https://oilwellcbd.com/

Order today and experience the OilWell difference. We ship directly to Chattooga County, Georgia — bringing Houston-quality cannabis medicine to the beautiful Appalachian communities we proudly serve.

Final Legal Disclaimer: These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease. Individual results may vary. Consult your healthcare provider before using any cannabinoid products, especially if you have a medical condition, are taking medications, are pregnant or nursing, or have health concerns. Do not operate vehicles or machinery while under the influence of psychoactive cannabinoids. You must be 21 years or older to purchase. Compliance with all local Georgia laws and regulations is the responsibility of the consumer.